Lilly sees launching weight loss drugs in China, India starting late 2025 – Seeking Alpha

Lilly sees launching weight loss drugs in China, India starting late 2025  Seeking Alpha

The State of Weight Loss Drugs – The Motley Fool

The State of Weight Loss Drugs  The Motley Fool

The State of Weight Loss Drugs – The Motley Fool

The State of Weight Loss Drugs  The Motley Fool

Novo’s Wegovy successor disappoints in second large trial – BioPharma Dive

Novo’s Wegovy successor disappoints in second large trial  BioPharma Dive

Novo Nordisk shares fall on weight-loss drug trial – MSN

Novo Nordisk shares fall on weight-loss drug trial  MSN

Sugar reduction and GLP-1s – Food Business News

Sugar reduction and GLP-1s  Food Business News

Novo Nordisk shares fall on weight-loss drug trial – Fox Business

Novo Nordisk shares fall on weight-loss drug trial  Fox Business

IA-2A positivity identified as a key predictor in type 1 diabetes progression

A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a…

Novo Nordisk shares fall on weight loss drug trial results – Proactive Investors USA

Novo Nordisk shares fall on weight loss drug trial results  Proactive Investors USA

Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain. – Barron’s

Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain.  Barron’s